Becker's Healthcare January 2, 2025
President-elect Donald Trump has chosen two prominent men to lead health-related affairs in his administration, Mehmet Oz, MD, and Robert Kennedy, Jr.
While the two leaders will be leading health affairs, they differ on one key issue — GLP-1 weight loss medications.
Dr. Oz has publicly praised GLP-1s for their benefits, even pitching them on television and social media channels, according to a Dec. 30 report from The Hill.
On the other hand, Mr. Kennedy expressed his belief that such medications are a scam.
“The first line of response should be lifestyle. It should be eating well, making sure that you don’t get obese,” Mr. Kennedy said in a Dec. 12 interview. He also suggested that GLP-1s...
Today's Sponsors
Today's Sponsor